Victory Square Technologies's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 22.41.
Victory Square Technologies's Days Inventory for the
three
months ended in Mar. 2026 was 0.
Victory Square Technologies's Days Payable for the
three
months ended in Mar. 2026 was 7.95.
Therefore, Victory Square Technologies's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 14.46.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Victory Square Technologies Cash Conversion Cycle Related Terms
Victory Square Technologies Cash Conversion Cycle Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VSQTF vs VEEV, BTSG, TEM: Cash Conversion Cycle Comparison
For the Health Information Services subindustry, Victory Square Technologies's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Victory Square Technologies Cash Conversion Cycle vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Victory Square Technologies's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Victory Square Technologies's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Victory Square Technologies's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Victory Square Technologies (VSQTF) has a Cash Conversion Cycle of 14.46 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Victory Square Technologies and its competitors.
Is Victory Square Technologies' Cash Conversion Cycle too high?
Victory Square Technologies' current Cash Conversion Cycle is 14.46. The Healthcare Providers & Services industry median Cash Conversion Cycle is 18.10. Victory Square Technologies' value of 14.46 is 20.1% below this industry median. Overall, Victory Square Technologies has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Victory Square Technologies' Cash Conversion Cycle compare to VEEV and BTSG?
Victory Square Technologies' Cash Conversion Cycle of 14.46 can be compared against companies in the Healthcare Providers & Services industry. The industry median Cash Conversion Cycle is 18.10. Victory Square Technologies' value of 14.46 is 20.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Healthcare Providers & Services company?
The median Cash Conversion Cycle among Healthcare Providers & Services companies is 18.10, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Victory Square Technologies's current Cash Conversion Cycle of 14.46 is 20.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Victory Square Technologies and its competitors. For the Healthcare Providers & Services industry, the median Cash Conversion Cycle is 18.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Victory Square Technologies's current Cash Conversion Cycle is 14.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Victory Square Technologies stock overvalued right now?
Based on GuruFocus' analysis, Victory Square Technologies (VSQTF) is currently considered Fairly Valued. The stock's GF Value™ is $0.55, compared to a current price of $0.51 — trading 7.2% below its estimated fair value. The current Cash Conversion Cycle is 14.46 and 20.1% below the Healthcare Providers & Services industry median of 18.10. Victory Square Technologies' overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Victory Square Technologies (VSQTF), the current Cash Conversion Cycle is 14.46 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Victory Square Technologies (VSQTF) Overvalued in 2026?
Based on GuruFocus' analysis, Victory Square Technologies stock appears to be undervalued.
The current stock price of $0.51 is trading 7.2% below its estimated GF Value™ of $0.55.
GuruFocus considers Victory Square Technologies to be Fairly Valued.
Key valuation signals for VSQTF:
Cash Conversion Cycle: 14.46
GF Value™: $0.55 vs. price of $0.51 (7.2% below fair value)
Industry Position: 20.1% below the Healthcare Providers & Services median
No single metric tells the full story. See the VSQTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Victory Square Technologies Inc is focused on investing in disruptive innovation builds, acquires, and invests in startups, then provides the senior leadership and resources needed for fast-track growth. Victory Square provides investors with a liquid way to invest in early-stage technology and healthcare companies without buying a venture fund that requires accredited investor status or multi-year commitments. The firm's corporate portfolio consists of companies using Artificial intelligence (AI), Virtual reality (VR), Augmented reality (AR), and blockchain to disrupt sectors as diverse as fintech, insurance, health, and gaming. The segments of the company are Investments; Health Tech; and Health.
48GF Score
Get the complete analysis for VSQTF
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VSQTF has been successfully added to your 
